checkAd

     457  0 Kommentare Meridian Bioscience Provides an Update on the Revogene SARS-CoV-2 EUA Submission - Seite 2

    About Meridian Bioscience, Inc.
    Meridian is a fully integrated life science company that develops, manufactures, markets and distributes a broad range of innovative diagnostic products. We are dedicated to developing and delivering better solutions that give answers with speed, accuracy and simplicity that are redefining the possibilities of life from discovery to diagnosis. Through discovery and development, we provide critical life science raw materials used in immunological and molecular tests for human, animal, plant, and environmental applications. Through diagnosis, we provide diagnostic solutions in areas including gastrointestinal and upper respiratory infections and blood lead level testing. We build relationships and provide solutions to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers, and biotech companies in more than 70 countries around the world.

    Meridian’s shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian’s website address is www.meridianbioscience.com.

    Contact:
    Charlie Wood
    Vice President – Investor Relations
    Meridian Bioscience, Inc.
    Phone: +1 513.271.3700
    Email: mbi@meridianbioscience.com


    Seite 2 von 2




    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Meridian Bioscience Provides an Update on the Revogene SARS-CoV-2 EUA Submission - Seite 2 CINCINNATI, Feb. 16, 2021 (GLOBE NEWSWIRE) - Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, provided an update on its application for Emergency Use Authorization (EUA) with the …